AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS

Go back to AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS

Amgen (AMGN) falls 3% after-hours following slight Q1 revenue miss

April 27, 2023 4:12 PM UTC

Amgen (NASDAQ: AMGN) falls 3% after-hours following a slight Q1 revenue miss and so-so guidance:

Amgen reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.Amgen sees Q2... More

Amgen (AMGN) Tops Q1 EPS by 16c

April 27, 2023 4:02 PM UTC

Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.

GUIDANCE:

Amgen sees FY 2023 EPS of $17.60-$18.70, versus the consensus of $17.72. Amgen sees FY... More